TSPYL5 and lung carcinoma: Treatment with the TS120-T peptides in other lung cancer cells with high levels of TSPYL5, such as H358 and H2009 (Supplementary Fig. 1), also inhibited cell growth and enhanced the sensitivity of the cells to γ-radiation and gefitinib (Supplementary Fig. 11b).